Skyward Specialty Insurance Group, Inc.

Fundamentals8.0
Price Action6.0
News Sentiment7.0
AI Rating
7.0

Key Drivers

  • High profitability
  • Large receivables
  • Substantial deferred revenue

AI
AI Summary

7.0

Skyward has shifted from a mid‑cycle specialty insurer to a leveraged, multicompartment specialty platform with Lloyd's syndicate access—creating upside via fee income and scaled underwriting but making near‑term value hinge on successful Apollo/Lloyd's integration, deleveraging and upcoming reserve reviews. Monitor FCF-driven debt reduction, Q4 2025 reserve outcomes, and early syndicate fee cadence as the three specific catalysts that will validate or invalidate the investment case.

FreeCashFlow
Leverage
Lloyds‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

8.0

Key Financial Insights:

  • High profitability
  • Large receivables
  • Substantial deferred revenue

SKWD combines strong operating profitability and exceptional free‑cash‑flow conversion with moderate valuation and a net‑cash position, but material deferred revenue and very high receivables create significant cash‑conversion and collection risk.

StrongFCF
ReceivableRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below average
  • Downward momentum
  • Elevated volatility

SKWD is trading below its last-month average (close $41.26 vs ~ $45.90), signaling short-term downside momentum with primary support at $41.26, immediate resistance around $46–47 and a nearby zone at $48–49 after a volatile early‑March drop.

bearish
mixed
Support Level: $41.26
Resistance Level: $46.00–$47.00 (nearby), $48.00–$49.00 (zone)

Rapid early‑March fall produced above‑normal short‑term volatility (~17% of last month mean)

Sentiment & News

7.0

Key News Insights:

  • Beat estimates
  • Niche underwriting
  • Leverage concerns

Skyward Specialty beat Q4 and FY25 estimates with strong earnings and reaffirmed niche-underwriting plus fee-income growth that attracted analyst upgrades and a CEO buy, though near-term leverage and Apollo-related pullback raise balance-sheet risks.

Outperform
WatchBalance

Solid earnings and strategy underpin upside potential, but expect near-term volatility as balance-sheet pressure and recent pullback are resolved